SLC16A3 and carcinoma: Altogether, our data demonstrate that fibroblast MCT4 is a driver of carcinoma cell aggressiveness, and that the detrimental effect of NAC on carcinoma cells may be partially mediated by the downregulation of MCT4 in fibroblasts.